Faber

Venture Capital

Faber is a Lisbon-based venture capital firm investing in technology and science startups across digital transformation and climate sectors.

Website

Portfolio

companies

Portfolio companies

iLoF

iLoF develops an artificial intelligence powered photonics platform for personalised medicine.

Abtrace

Abtrace uses machine learning and artificial intelligence to transform the detection and treatment of chronic health conditions.

Team

Sofia Santos

Partner

Sofia is a partner at Faber, having previously worked as an investment manager and venture developer at Faber Ventures. Her earlier career includes consulting roles at Jason Associates, Ray Human Capital, and SDO Consultoria.

Recent investments

Seed28 July 2022

£3.4M

iLoF secures 3.38m in seed funding led by Faber to accelerate personalized drug discovery platforms.

AI/ML MedTech BioTech HealthTech

The seed round was led by Faber with participation from international venture funds to support clinical trial operations.

"For hundreds of years, treatments have been developed with the assumption they will work for everyone. However, each person is different, and for many severe diseases such as Alzheimer’s, multiple factors can contribute to the effectiveness of a treatment on a given patient."

— Luis Valente, Co-Founder and CEO

iLoF—London, UK

Faber + 8 others

Seed26 August 2021

£2.1M

Abtrace raises £2.1m in a seed round led by Faber to expand its healthtech platform across UK surgeries

AI/ML Big Data HealthTech

The funding round was led by Faber with participation from Ganexa Capital and Innovate UK.

"As it stands, the management of long-term health conditions is an inefficient process for patients and their GP practice. It involves multiple appointments, duplication of tests, and tons of admin. It doesn’t deliver the best for patients and also wastes valuable NHS time and resources. Abtrace is working at the interface of AI and healthcare to transform this."

— Umar Naeem Ahmad, CEO

Abtrace—London, UK

Faber + 2 others